|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Profit loss | |||||
| Items not affecting cash | |||||
| Deferred income tax (recovery) expense | |||||
| Depreciation | |||||
| Amortization of right-of-use assets | |||||
| Impairment of exploration and evaluation assets | |||||
| Interest expenses on lease liability | |||||
| Interest and standby fees on gold loan payable | |||||
| Unrealized (gain) loss on derivative financial liabilities | |||||
| Gain on sale of property and equipment | |||||
| Fair value adjustments on gold loan payable | |||||
| Unrealized gain on gold in trust | |||||
| Unrealized foreign exchange (gain) loss on gold loan payable | |||||
| Unrealized foreign exchange (gain) loss on gold in trust | |||||
| Unrealized gain on warrant liability | |||||
| Loss on derecognition of gold loan payable | |||||
| Share-based payments | |||||
| Accounts receivable and prepaid expenses | |||||
| Trade and other payables | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Property and equipment – purchase | |||||
| Net proceeds on sale of property and equipment | |||||
| Exploration and evaluation assets – costs | |||||
| Net cash from (used in) investing activities | |||||
| Financing activities | |||||
| Issuance of shares, net of share issue costs | |||||
| Options exercised | |||||
| Shares issuance cost on cashless exercise of options | |||||
| Repayment of gold loan payable | |||||
| Repayment of lease liabilities | |||||
| Net cash used in financing activities | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...